Further studies revealed that AS-IV inhibited the activation of two key signaling molecules, ERK1/2 and JNK, members of the MAPK family, and downregulated the matrix metalloproteinases MMP-2 and MMP-9, which ultimately inhibited the invasive function of tumor cells. Here, MAPK3 is linked to neoplasm.